Phase I/IIA Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects.
Phase of Trial: Phase I/II
Latest Information Update: 02 Mar 2011
At a glance
- Drugs HIV vaccine (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 02 Mar 2011 Results presented at the 18th Conference on Retroviruses and Opportunistic Infections.
- 23 Feb 2011 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History